News

Oakmark Funds, advised by Harris Associates, released its “Oakmark Equity and Income Fund” Q2 2025 investor letter. A copy of ...
The move is expected to bolster Zimmer’s ROSA Robotics platform with Monogram's semi-autonomous and fully autonomous robotic ...
Zimmer Biomet inked a $177 million deal to purchase Monogram Technologies, developer of a hands-free robotic surgery system ...
Zimmer Biomet it will acquire robotics firm Monogram Technologies for about $177 million, adding Monogram’s semi- and fully ...
Monogram develops semi- and fully autonomous robotic technologies. Zimmer Biomet expects its offerings to add new, ...
Shares of Monogram Technologies (NASDAQ:MGRM) jumped 60% following news that Zimmer Biomet (NYSE:ZBH) has agreed to acquire ...
Zimmer Biomet Holdings, Inc. has a definitive agreement to acquire all outstanding shares of the AI-driven orthopedic ...
Zimmer Biomet has agreed to buy Monogram Technologies in a deal with an equity value of about $177 million.
Zimmer Biomet and Getinge announced today announced a strategic partnership related to ambulatory surgical centers (ASCs).
This was the stock's second consecutive day of losses.
Zimmer Biomet's ZBH strategic product launches and stabilizing market trends bolster our confidence in this stock. However, factors like macroeconomic uncertainties put pressure on the bottom line.
The Monogram acquisition will contribute to revenue growth in 2027 by improving Zimmer Biomet's robotic knee adoption in the ...